SM Energy SM

At a glance

One-line thesis. SM Energy — a century-old Denver-based oil and gas producer across the Midland Basin, South Texas, and the Uinta Basin — appears to have closed a transformational acquisition in Q1 2026 (revenue +76% YoY, interest expense ~3×, implied net debt ~3× to ~$7.5B), leaving a stock that screens extremely cheap on consensus (~3.5× 2026E EPS as stated, EV ~3.0× 2026E EBITDA) but carries real leverage, pure commodity-price exposure, a deeply oversold falling tape (RSI 20, −24% off the high), and material inconsistencies in our own data file — so this is a Watch, not a buy, until the setup or the disclosure improves.

1. What it is

SM Energy (NYSE: SM) is an independent oil and gas exploration & production company founded in 1908 (renamed from St. Mary Land & Exploration in May 2010), headquartered at 1775 Sherman Street, Denver, CO; CEO Elizabeth Anne McDonald; ~663 employees; IPO 1992. It explores for, develops, and produces oil, natural gas, and NGLs.

Revenue mix — three basins, oil-weighted:

• By area (FY2025, from filings): Midland Basin $1.37B (44%) · South Texas $0.89B (28%) · Uinta Basin $0.88B (28%) of $3.15B total. The Uinta Basin is new — it first appears in FY2024 at $204M (alongside a ~$2.1B investing outflow that year, i.e., an acquisition) and scaled to $875M in FY2025.
• By product (FY2024, last year split was disclosed): Oil $2.19B (~82%) · Natural gas $249M · Oil & condensate $235M. FY2025 is reported as a single E&P segment ($3.15B).
• Data caveat — the profile is stale: the FMP company description still says operations are "exclusively concentrated within the state of Texas" and cites Feb-2022 reserves (492 MMBoe, 825 oil / 483 gas wells). The segment data above contradicts the Texas-only claim (Uinta is Utah), so treat the reserve/well figures as dated.

The Q1 2026 transformation (visible in the numbers, unnamed in our data): Q1 2026 revenue was $1.48B, +76% YoY (vs $840M in Q1 2025); quarterly interest expense jumped to $113M (vs ~$43M/qtr through most of 2025); implied net debt in the TTM metrics is ~$7.5B vs $2.49B at YE2025; and consensus 2026 revenue is $7.36B vs $3.15B actual in 2025 (+133%). That pattern is a large, debt-and-stock-funded acquisition closing during Q1 2026. Our data file does not identify the counterparty — we flag rather than guess.

2. The expert thesis — panel coverage (traceable)

No expert-panel coverage — this note is fundamentals-driven. A search of the Synthos KB returns zero traceable claims on SM (kb_breadth 0, kb_claim_count 0). That is the honest house standard for a screen-surfaced name: SM entered the pipeline through the quant momentum screen (6-mo return +41% vs SPY +10%), not through conviction voices. There is no high-skill bull or bear to weigh here, and we do not manufacture one — the bull and bear cases in §3 are built entirely from the filed financials, live consensus estimates, and technicals in the data file. Conviction is scored Low accordingly, and the verdict is deliberately conservative.

3. Synthos scores & the Bull / Base / Bear cases

The one-glance judgment — three scores, 0–10, each anchored to real metrics:

The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We do not attach probabilities; the base case is the expected path and the cases bound the range.

Synthos fair value = the base case, ~$36 (+37%), range $22–$48. Unusually for a Synthos note, our base is the Street consensus — deliberately: with no expert panel and a data file carrying share-count conflicts, sell-side targets (set with full knowledge of the actual deal terms) are the least-bad anchor, and we label that dependence plainly. This is a tracked call — the Forecaster Scorecard grades it once it matures.

4. Exponential Potential

Synthos separates compounders (durable high returns on capital) from exponentials (accelerating multi-baggers). SM is neither — it is a leveraged commodity value/deleveraging story:

• Forward growth: consensus revenue $7.36B (2026E) → $7.25B (2030E) — a negative ~0.4%/yr drift. EPS $7.58E → $8.67E is a ~3.4% CAGR, driven by margin/interest assumptions, not volume growth.
• Acceleration (2nd derivative): negative-to-flat. The one big step-up (2026E, +133%) is the acquisition landing; after that, estimates flatline. There is no compounding engine here.
• Room to run — the honest version: the upside is financial, not operational: net debt ~$7.5B vs 2026E EBITDA of $4.63B is ~1.6× on forward numbers — if that EBITDA lands, rapid deleveraging plus a re-rate from ~3.0× EV/2026E-EBITDA toward a normal 4–5× is the whole bull case. That is a real, bounded one-time gain — not an exponential.
• Reinvestment economics: E&P capex is a treadmill, not a runway — FY25 capex was 46% of revenue ($1.44B of $3.15B), and TTM capex ran 110% of operating cash flow (deal-inflated). Returns on capital (TTM ROIC ~1.1%) are currently poor.

Exponential Potential: Low (2/10). Own it (if at all) for the value gap and the dividend, never for compounding.

5. Financials (real numbers — FMP annual/quarterly)

• Revenue: FY2025 $3.15B, +18.1% (FY2024 $2.67B, +13.0%; FY2023 $2.36B, −29.4% off the FY2022 commodity-spike peak of $3.35B). TTM revenue (last four quarters) is $3.79B, already reflecting one deal-inflated quarter.
• Quarterly trajectory — the deal is visible: Q1'25 $840M → Q2'25 $785M → Q3'25 $811M → Q4'25 $718M → Q1'26 $1,479M (+76% YoY). Street expects ~$2.02B for Q2 2026 — the first full post-deal quarter.
• Q1 2026 GAAP loss — read carefully. The income statement shows a net loss of $335M (GAAP EPS −$2.91), driven by a $1,175M "other expenses" line (transaction/impairment/hedge-type items — the file does not itemize) and D&A of $432M, while the earnings calendar records adjusted EPS of $1.55 vs $1.13 estimated (a beat) on a revenue beat ($1,479M vs $1,418M est). Underwrite the adjusted/cash numbers, not the GAAP headline.
• Margins: TTM gross margin 45.1%, EBITDA margin 54.3%, but operating margin only 6.5% and net margin 3.4% — both crushed by the Q1'26 charges. Clean-year FY2025: operating income $822M (26.1% of revenue), net income $648M (20.5%), EPS $5.65.
• Cash flow: FY2025 OCF $2.01B, capex $1.44B, FCF $573M, dividends paid $92M, buybacks a token $13M. FY2024 FCF was −$1.63B on FMP's presentation — that year's ~$2.1B "other investing" outflow (the Uinta entry) is folded into the capex line, so the negative FCF is acquisition-driven, not operational. TTM FCF is negative again (FCF/share −$1.96 on the file's 115M-share basis; capex 110% of OCF) — the new deal is consuming cash for now.
• Balance sheet: at YE2025 — total assets $9.25B, cash $368M, total debt $2.85B, net debt $2.49B (≈1.1× FY25 EBITDA of $2.21B), equity $4.81B. Post-deal (TTM metrics): implied net debt ~$7.5B, netDebt/EBITDA 3.66× TTM, falling to ~1.6× on 2026E EBITDA of $4.63B if estimates land. Current ratio 0.39 (short-term debt $477M at YE25). Zero goodwill/intangibles — the book is rock and pipe.
• Data-quality flags (honest list): (1) the FY2025 balance sheet misclassifies ~$8.2B of what is plainly PP&E into "other assets" (PP&E shows $65M vs $7.99B in FY2024); (2) Q4'25 interest expense shows $302.9M — impossible against the FY2025 total of $173M, so the TTM interest-coverage ratio (0.49×) is distorted by a bad quarter line; (3) market cap ($6.32B) vs the 115M weighted shares used in every per-share figure implies two different companies — see §3. None of these are resolvable from the file; we flag all three.

6. Valuation — priced in or room?

On the file's stated numbers, SM is one of the cheapest names we have run: ~3.5× 2026E EPS ($7.58) and ~3.3× 2027E ($7.89), EV/EBITDA 6.7× TTM falling to ~3.0× on 2026E EBITDA ($4.63B), EV/S 3.6×, 0.44× price-to-book, and a 3.19% dividend yield ($0.84/share). FMP's rating is B+ (overall 3/5) with the tell-tale value split: DCF score 5/5 and P/B 5/5, but P/E 1/5 and debt/equity 1/5 — cheap assets, ugly leverage. Even under the adverse share-count reading (~240M shares → consensus EPS effectively ~$3.6–3.9), the forward P/E is ~7× — still cheap for the sector. The honest framing: the market is pricing leverage + oil-price risk + post-deal uncertainty, not ignorance. A reverse read: at $26.35 you need no growth at all — only that consensus 2027 earnings roughly land and the balance sheet delevers on schedule. Street targets (context and, here, anchor): consensus $36, median $32, range $29–$55; 33 Buy / 17 Hold / 4 Sell. The narrow low end ($29, above today's price) says the sell side sees the leverage as manageable; the price says the market is less sure. Not a quality compounder at a discount — a levered value bet on oil and execution.

7. Technicals (from the tech block)

• Trend: damaged. $26.35 is below the 50-DMA ($30.23) and only ~8% above the 200-DMA ($24.48). MACD −1.36 (negative).
• Location: −24% off the 52-week high ($34.81), +50% off the 52-week low ($17.57); max drawdown from peak −51.5% — this stock halves when it goes wrong.
• Momentum: RSI(14) 20 — deeply oversold, the kind of reading that precedes bounces but also accompanies breakdowns; it is a setup flag, not a buy signal by itself.
• Relative strength (the tell): 3-mo −13.9% vs SPY +14.6% / QQQ +23.6% — sharp recent underperformance. 6-mo +40.9% vs SPY +10.2% (the rally that put it on our momentum screen). 12-mo +0.6% vs SPY +21.1% — a round trip.
• Read: technicals are weak — a completed momentum rally now in sharp correction. The actionable line for the Watch trigger: a hold-and-base above the 200-DMA (~$24.5) with RSI recovering through ~40, or capitulation toward the $17.5–$20 zone where the bear-case math gets undemanding. Below the 200-DMA, there is no technical case at all.

8. Moat & competitive position

E&P companies do not have moats in the classic sense — SM's competitive position is its rock quality and cost basis in three areas: the Midland Basin (core Permian, 44% of FY25 revenue), South Texas (28%), and the newly scaled Uinta Basin (28%). Diversification across three basins is a genuine risk-spreader versus single-basin peers, and the Uinta's waxy-crude niche has fewer operators. But there is no pricing power anywhere in the model — SM is a price-taker on ~82% oil-weighted revenue (FY24 split), and its returns are set by the commodity cycle and its own well costs. TTM ROIC of ~1.1% (loss-distorted; FY25 was materially better) does not evidence durable advantage.

Peer set (FMP-supplied, market cap): BKV $2.96B, Civitas Resources $2.34B, Crescent Energy $3.02B, Cosan $2.97B, Delek US $3.25B, Kinetik $3.49B, Northern Oil & Gas $1.89B, DHT $2.76B, Teekay Tankers $2.38B, TORM $2.87B. Caveat: the list mixes shale E&Ps with tankers and refiners — judge SM against the mid-cap shale cohort (CIVI, CRGY, NOG), not the shipping names. Notably, every listed peer sits in the $1.9–3.5B cap band, which is FMP's cap-matching at work — one more hint that the file's $6.32B market-cap print for SM is the anomalous figure.

9. Management, capital allocation & guidance

• Leadership: CEO Elizabeth Anne McDonald (per the profile). Our file contains no tenure or track-record data on her — honestly, we know less about this management team than we would want before upgrading the verdict.
• Capital allocation: the recent record is acquisition-heavy — the ~$2.1B Uinta entry in FY2024 (funded with $1.2B of new debt), then the far larger Q1 2026 transaction that took implied net debt to ~$7.5B. Alongside: a steady, modest dividend ($0.84/share, $92M paid in FY25, ~3.2% yield, well covered by FY25's $573M FCF) and token buybacks ($13M FY25). This is a team betting the company on scale; the dividend is the shareholder-return fig leaf until the debt comes down. TTM dividend payout shows >100% of GAAP EPS — an artifact of the Q1'26 GAAP loss, covered on a cash basis.
• Insider activity: the only recent Form 4s (filed 2026-07-02) are EVP/GC James Lebeck's RSU vestings — M-Exempt share acquisitions at $0 with in-kind tax-withholding disposals at $26.10. Routine compensation mechanics; no discretionary buying or selling signal either way.
• Guidance: our data file contains no management guidance (no earnings-call ingest for SM on our plan). The Street's Q2 2026 marks — EPS $2.00, revenue ~$2.02B — are the de facto bar for 2026-07-30.

10. Catalysts & what to watch

• Next earnings: 2026-07-30 (Q2 2026; Street EPS $2.00, revenue ~$2.02B) — the first full post-deal quarter. The key lines: the actual share count (resolving our data conflict), pro-forma leverage and the deleveraging schedule, and any synergy/integration guidance. Recent print record is good: adjusted EPS beat in each of the last four quarters ($1.55 vs $1.13; $0.83 vs $0.828; $1.33 vs $1.25; $1.50 vs $1.25).
• Oil and gas prices: the entire consensus stack (2026E EBITDA $4.63B) is a commodity-price derivative; a sustained crude downdraft rewrites every number in this note.
• Deleveraging milestones: debt paydown announcements or asset sales — the fastest path from ~3.7× TTM leverage toward the ~1.6× forward figure the estimates imply.
• Technical repair: a base above the 200-DMA (~$24.5) with RSI recovering — the Watch-to-Tactical trigger.
• Dividend integrity: the $0.84 payout surviving the leverage phase is the market's live stress-gauge.

Thesis tripwires (what would change the call): a Q2 miss or guidance cut on 2026-07-30; a dividend cut; net debt failing to decline over the next two quarters; a decisive close below the 200-DMA on volume; or WTI-driven estimate revisions dragging 2027E EPS below ~$6.

11. Key risks

• Commodity price (the dominant risk): revenue, EBITDA, the deleveraging plan, and the dividend all float on oil (~82% of the FY24 revenue split). No hedge-book detail is in our file — an unknown we flag.
• Leverage into a downturn: implied net debt ~$7.5B against $2.06B TTM EBITDA (3.66×); a current ratio of 0.39; TTM FCF negative. The forward comfort (~1.6× on 2026E EBITDA) depends entirely on estimates landing.
• Integration/execution: the Q1 2026 transaction roughly doubled the company; integration stumbles, synergy shortfalls, or culture/asset surprises are classic post-deal risks — and we cannot even name the counterparty from our data.
• Data integrity (unusual, but real): market-cap/share-count conflict, a garbled FY25 PP&E line, and an impossible Q4'25 interest figure in the file mean several ratios here carry error bars. We have flagged each where used.
• GAAP noise: Q1'26's $1.18B other-expense line produced a −$2.91 GAAP EPS against +$1.55 adjusted — headline screens will misread this name in both directions.
• Governance/informational: no expert-panel coverage, no management-guidance ingest, and a stale company profile — our information edge here is thin, which is itself a risk and a reason for the conservative verdict.
• Technical: momentum is negative now (RSI 20, below 50-DMA, 3-mo −14% vs SPY +15%); oversold can get more oversold.

12. Verdict, position sizing & monitoring

Watch. The value math is genuinely tempting — ~3.3–3.5× stated 2027E/2026E EPS (~7× even under the adverse share-count reading), ~3.0× EV/2026E EBITDA, 0.44× book, a covered 3.2% dividend, a Street that is 33-Buy/4-Sell with even its low target ($29) above the price. But three things keep this out of the Buy tiers today: (1) leverage — ~3.7× TTM net-debt/EBITDA immediately post-deal, with the comfortable forward ratio still hypothetical; (2) the price action — RSI 20, below the 50-DMA, 3-mo relative strength of −29 points vs SPY; catching this knife is a timing decision we refuse to dress up as a valuation one; (3) informational thinness — no panel coverage, no guidance ingest, and unresolved share-count conflicts in our own data. Watch, with defined triggers.

• Triggers to upgrade (Watch → Buy — Tactical): a clean 2026-07-30 print (share count disclosed, leverage path affirmed, EPS ≥ the $2.00 mark) or a confirmed technical base above the 200-DMA (~$24.5) with RSI repaired through ~40 — either one, at a price at or below ~$27, keeps the +33%-to-base margin intact.
• Sizing if triggered: satellite, ≤1–2% of the flagship — sized for a name with a −52% historical max drawdown and commodity-linked earnings, never a core anchor.
• Monitoring: re-underwrite on the §10 tripwires; formal re-score at each print (next 2026-07-30). This verdict is logged as a tracked Synthos call as of 2026-07-06 at $26.35.
• Single biggest risk: an oil-price downdraft against a freshly tripled debt load — the scenario where cheap gets cheaper and the equity, not the bondholder, absorbs it.

Provenance & disclosures

• Traceability: zero KB claims on SM (breadth 0, claim count 0) — no expert-panel coverage, and none is invented; kb_net_conviction is null because there is nothing to aggregate. This note is built entirely from the FMP data file (profile, filings-derived statements, consensus estimates, price targets, grades, insider filings, technicals).
• Data as-of: fundamentals 2026-03-31 (Q1 2026, filed 2026-05-07) · estimates and prices 2026-07-06 (file pull) · no KB claims. Forward figures are analyst consensus (FMP), labeled as estimates.
• Data-quality caveats (material, disclosed in-line): (1) market cap $6.32B vs 115M weighted shares (~$3.0B implied) — a post-deal share-count conflict we flag rather than resolve; (2) FY2025 balance sheet misclassifies ~$8.2B of PP&E into "other assets"; (3) Q4'25 interest expense ($302.9M) is inconsistent with the FY2025 annual total ($173M), distorting the TTM coverage ratio; (4) the company profile text is stale (Texas-only, Feb-2022 reserves) versus the filed segment data (Uinta Basin since FY2024).
• Anchor disclosure: the base-case fair value adopts the $36 Street consensus target — a deliberate choice given zero panel coverage and the share-count ambiguity; our multiple cross-check (~4.6× 2027E consensus EPS) is shown with its assumptions.
• Earnings-quality caveat: Q1 2026 GAAP EPS (−$2.91) diverges from adjusted EPS (+$1.55) by ~$4.5/share on deal-related charges; underwrite adjusted/cash figures.
• Peer caveat: the FMP-supplied peer list mixes shale E&Ps with tanker and refining names; judge SM against the mid-cap shale cohort.
• Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
• Version: 2026-07-06. Prior versions available via the deep-dive version dropdown ("based on the info at the time").